Biblio

Export 2680 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Keyword is A  [Clear All Filters]
2024
J. Wang, Zhang, G., Lai, H., Li, Z., Shen, M., Li, C., Kwan, P., O'Brien, T. J., Wu, T., Yang, S., Zhang, X., and Zhang, L., “Characterizing Gut Microbiota in Older Chinese Adults with Cognitive Impairment: A Cross-Sectional Study.”, J Alzheimers Dis, vol. 101, no. 3, pp. 761-771, 2024.
C. L. Satizabal, Himali, J. Jung, Conner, S. C., Beiser, A. S., Maillard, P., Vasan, R. S., DeCarli, C., and Seshadri, S., “Circulating adipokines and MRI markers of brain aging in middle-aged adults from the community.”, J Alzheimers Dis, vol. 102, no. 2, pp. 449-458, 2024.
C. L. Satizabal, Himali, J. Jung, Conner, S. C., Beiser, A. S., Maillard, P., Vasan, R. S., DeCarli, C., and Seshadri, S., “Circulating adipokines and MRI markers of brain aging in middle-aged adults from the community.”, J Alzheimers Dis, vol. 102, no. 2, pp. 449-458, 2024.
C. L. Satizabal, Himali, J. Jung, Conner, S. C., Beiser, A. S., Maillard, P., Vasan, R. S., DeCarli, C., and Seshadri, S., “Circulating adipokines and MRI markers of brain aging in middle-aged adults from the community.”, J Alzheimers Dis, vol. 102, no. 2, pp. 449-458, 2024.
C. L. Satizabal, Himali, J. Jung, Conner, S. C., Beiser, A. S., Maillard, P., Vasan, R. S., DeCarli, C., and Seshadri, S., “Circulating adipokines and MRI markers of brain aging in middle-aged adults from the community.”, J Alzheimers Dis, vol. 102, no. 2, pp. 449-458, 2024.
C. L. Satizabal, Himali, J. Jung, Conner, S. C., Beiser, A. S., Maillard, P., Vasan, R. S., DeCarli, C., and Seshadri, S., “Circulating adipokines and MRI markers of brain aging in middle-aged adults from the community.”, J Alzheimers Dis, vol. 102, no. 2, pp. 449-458, 2024.
C. L. Satizabal, Himali, J. Jung, Conner, S. C., Beiser, A. S., Maillard, P., Vasan, R. S., DeCarli, C., and Seshadri, S., “Circulating adipokines and MRI markers of brain aging in middle-aged adults from the community.”, J Alzheimers Dis, vol. 102, no. 2, pp. 449-458, 2024.
C. Rosario Ilardi, Menichelli, A., Michelutti, M., Cattaruzza, T., Federico, G., Salvatore, M., Iavarone, A., and Manganotti, P., “On the Clinimetrics of the Montreal Cognitive Assessment: Cutoff Analysis in Patients with Mild Cognitive Impairment due to Alzheimer's Disease.”, J Alzheimers Dis, vol. 101, no. 1, pp. 293-308, 2024.
C. Rosario Ilardi, Menichelli, A., Michelutti, M., Cattaruzza, T., Federico, G., Salvatore, M., Iavarone, A., and Manganotti, P., “On the Clinimetrics of the Montreal Cognitive Assessment: Cutoff Analysis in Patients with Mild Cognitive Impairment due to Alzheimer's Disease.”, J Alzheimers Dis, vol. 101, no. 1, pp. 293-308, 2024.
C. Rosario Ilardi, Menichelli, A., Michelutti, M., Cattaruzza, T., Federico, G., Salvatore, M., Iavarone, A., and Manganotti, P., “On the Clinimetrics of the Montreal Cognitive Assessment: Cutoff Analysis in Patients with Mild Cognitive Impairment due to Alzheimer's Disease.”, J Alzheimers Dis, vol. 101, no. 1, pp. 293-308, 2024.
L. Fernández-Romero, Morello-García, F., Laforce, R., Delgado-Alonso, C., Delgado-Álvarez, A., Gil-Moreno, M. José, Lavoie, M., Matías-Guiu, J., Cuetos, F., and Matías-Guiu, J. A., “Comparative accuracy of Mini-Linguistic State Examination, Addenbrooke's Cognitive Examination, and Depistage Cognitif de Quebec for the diagnosis of primary progressive aphasia.”, J Alzheimers Dis, vol. 102, no. 1, pp. 67-76, 2024.
L. Fernández-Romero, Morello-García, F., Laforce, R., Delgado-Alonso, C., Delgado-Álvarez, A., Gil-Moreno, M. José, Lavoie, M., Matías-Guiu, J., Cuetos, F., and Matías-Guiu, J. A., “Comparative accuracy of Mini-Linguistic State Examination, Addenbrooke's Cognitive Examination, and Depistage Cognitif de Quebec for the diagnosis of primary progressive aphasia.”, J Alzheimers Dis, vol. 102, no. 1, pp. 67-76, 2024.
I. Terao and Kodama, W., “Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab, Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer's Disease”, J Alzheimers Dis, vol. 98, no. 3, pp. 825-835, 2024.
I. Terao and Kodama, W., “Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab, Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer's Disease”, J Alzheimers Dis, vol. 98, no. 3, pp. 825-835, 2024.
N. Puentes-Díaz, Chaparro, D., Reyes-Marquez, V., Morales-Morales, D., Flores-Gaspar, A., and Alí-Torres, J., “Computational Evaluation of the Potential Pharmacological Activity of Salen-Type Ligands in Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. s2, pp. S383-S396, 2024.
N. Puentes-Díaz, Chaparro, D., Reyes-Marquez, V., Morales-Morales, D., Flores-Gaspar, A., and Alí-Torres, J., “Computational Evaluation of the Potential Pharmacological Activity of Salen-Type Ligands in Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. s2, pp. S383-S396, 2024.
N. Puentes-Díaz, Chaparro, D., Reyes-Marquez, V., Morales-Morales, D., Flores-Gaspar, A., and Alí-Torres, J., “Computational Evaluation of the Potential Pharmacological Activity of Salen-Type Ligands in Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. s2, pp. S383-S396, 2024.
A. Mahzarnia, Lutz, M. W., and Badea, A., “A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer's Disease via ITGA5.”, J Alzheimers Dis, vol. 97, no. 2, pp. 635-648, 2024.
A. Mahzarnia, Lutz, M. W., and Badea, A., “A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer's Disease via ITGA5.”, J Alzheimers Dis, vol. 97, no. 2, pp. 635-648, 2024.
A. Mahzarnia, Lutz, M. W., and Badea, A., “A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer's Disease via ITGA5.”, J Alzheimers Dis, vol. 97, no. 2, pp. 635-648, 2024.
N. Vaishnav, Gonzalez, R., Karunungan, K., Tyler, A., Zheng, W., and Arias, J. J., “Creating an Unprotected Class: Addressing Legal Risks in the Era of Biologically-Defined Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 1, pp. 187-195, 2024.
C. E. Finch and Burstein, S. M., “Dementia in the Ancient Greco-Roman World Was Minimally Mentioned.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1581-1588, 2024.
C. E. Finch and Burstein, S. M., “Dementia in the Ancient Greco-Roman World Was Minimally Mentioned.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1581-1588, 2024.
M. S. Weinberg, He, Y., Kivisäkk, P., Arnold, S. E., and Das, S., “Effect of Metformin on Plasma and Cerebrospinal Fluid Biomarkers in Non-Diabetic Older Adults with Mild Cognitive Impairment Related to Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. s2, pp. S355-S365, 2024.
M. S. Weinberg, He, Y., Kivisäkk, P., Arnold, S. E., and Das, S., “Effect of Metformin on Plasma and Cerebrospinal Fluid Biomarkers in Non-Diabetic Older Adults with Mild Cognitive Impairment Related to Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. s2, pp. S355-S365, 2024.

Pages